비아트리스 (VTRS)

Jun 19, 2026

How Is Viatris’ Stock Performance Compared to Other Healthcare Stocks? - inkl

Jun 19, 2026

Jun 18, 2026

Viatris Inc. stock falls Thursday, underperforms market - MarketWatch

Jun 18, 2026

Jun 18, 2026

Viatris Completes €650 Million 4.250% Senior Notes Due 2033 to Refinance 2026 Debt - TradingView

Jun 18, 2026

Jun 18, 2026

Viatris (NASDAQ: VTRS) issues €650M 4.25% notes to help refinance 2026 debt - Stock Titan

Jun 18, 2026

Jun 18, 2026

(VTRS) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jun 18, 2026

Jun 17, 2026

Viatris Inc (VTRS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Viatris Inc. stock falls Wednesday, underperforms market - MarketWatch

Jun 17, 2026

Jun 17, 2026

Viatris Inc (VTRS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Viatris Inc (VTRS) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 16, 2026

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Jun 16, 2026

Jun 16, 2026

Viatris Recognized as One of the 2026 Best Workplaces™ in Canada - The Globe and Mail

Jun 16, 2026

Jun 16, 2026

Viatris Inc (VTRS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 16, 2026

Jun 15, 2026

Viatris launches €650M 4.250% senior notes due 2033 offering - TradingView

Jun 15, 2026

Jun 15, 2026

Viatris (VTRS) prices €650M 4.250% senior notes maturing 2033 - Stock Titan

Jun 15, 2026

Jun 15, 2026

Viatris (VTRS) sells €650M 4.25% senior notes to refinance 2026 debt - Stock Titan

Jun 15, 2026

Jun 15, 2026

Euro Bond Sale Might Change The Case For Investing In Viatris (VTRS) - simplywall.st

Jun 15, 2026

Jun 15, 2026

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth Prospects with an 8.09% Potential Upside - DirectorsTalk Interviews

Jun 15, 2026

Jun 14, 2026

Viatris (VTRS) Stock And The 58% Undervaluation Debate After A Strong Year Of Returns - Yahoo Finance

Jun 14, 2026

Jun 14, 2026

Viatris Euro Debt Raise Reshapes Capital Structure And Valuation Story - Yahoo Finance

Jun 14, 2026

Jun 13, 2026

Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune

Jun 13, 2026

Jun 12, 2026

Viatris Inc. stock rises Friday, outperforms market - MarketWatch

Jun 12, 2026

Jun 12, 2026

[424B5] Viatris Inc Prospectus Supplement (Debt Securities) - Stock Titan

Jun 12, 2026

Jun 11, 2026

A Look at Viatris Inc (VTRS) After 3.4% Gain -- GF Value $11.01 vs Price $16.31 - GuruFocus

Jun 11, 2026

Jun 11, 2026

VTRS News | VIATRIS INC (NASDAQ:VTRS) - ChartMill

Jun 11, 2026

Jun 11, 2026

Viatris Inc. stock rises Thursday, outperforms market - MarketWatch

Jun 11, 2026

Jun 09, 2026

Viatris Inc. stock rises Tuesday, outperforms market - MarketWatch

Jun 09, 2026

Jun 08, 2026

Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.70% Potential Upside with a Strong Dividend Yield - DirectorsTalk Interviews

Jun 08, 2026

Jun 07, 2026

Viatris (VTRS) Holds Steady Near Support Amid Flat Trading SessionRSI Overbought Alerts - newsline.com

Jun 07, 2026

Jun 07, 2026

Liquidity Mapping Around (VTRS) Price Events - Stock Traders Daily

Jun 07, 2026

Jun 07, 2026

FDA accepts Viatris' NDA for fast-acting non-opioid pain therapy - MSN

Jun 07, 2026

Jun 05, 2026

Investors brace for Viatris earnings as CFO departure looms By Investing.com - Investing.com Nigeria

Jun 05, 2026

Jun 04, 2026

Here's Why Viatris (VTRS) is a Strong Value Stock - Yahoo Finance

Jun 04, 2026

Jun 02, 2026

Salesforce : Agentforce Life Sciences Selected by Viatris as Its Global Customer Engagement Platform - marketscreener.com

Jun 02, 2026

Jun 02, 2026

Salesforce Agentforce Life Sciences Selected by Viatris as Its Global Customer Engagement Platform - Salesforce

Jun 02, 2026

Jun 01, 2026

Viatris Inc. stock falls Monday, underperforms market - MarketWatch

Jun 01, 2026

Jun 01, 2026

Viatris Inc. (VTRS) Stock Analysis: Exploring An 11% Potential Upside Amid Mixed Metrics - DirectorsTalk Interviews

Jun 01, 2026

May 31, 2026

Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune

May 31, 2026

May 31, 2026

Does FDA Review of Fast-Acting Meloxicam Shift Viatris’ (VTRS) Non-Opioid Pain Strategy? - simplywall.st

May 31, 2026

May 28, 2026

Viatris Top Brass Sued by Investor Over India Facility Problems - Bloomberg Law News

May 28, 2026

May 27, 2026

Argus Raises Viatris Price Target to $18 From $15 - Moomoo

May 27, 2026

May 27, 2026

Why (VTRS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

May 27, 2026

May 27, 2026

Analyst Report Highlights Viatris Inc’s Strategic Positioning Amid Generic Drug CompetitionLow Estimate Range - newsline.com

May 27, 2026

May 26, 2026

Viatris (VTRS) Under Pressure: Support Levels Tested After 1.5% DeclineVolatility Smile - newsline.com

May 26, 2026

May 25, 2026

Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035 - GlobeNewswire Inc.

May 25, 2026

May 25, 2026

Viatris Inc. (VTRS) Stock Analysis: Investor Outlook on a Healthcare Giant with an 8.44% Upside Potential - DirectorsTalk Interviews

May 25, 2026

May 24, 2026

Assessing Viatris (VTRS) Valuation After FDA Review Acceptance For Fast Acting Non Opioid Meloxicam - Yahoo Finance

May 24, 2026

May 21, 2026

What Viatris (VTRS)'s Fast-Acting Pain Drug Filing and Profit Uptick Means For Shareholders - simplywall.st

May 21, 2026

May 21, 2026

Viatris Inc.: - marketscreener.com

May 21, 2026

May 21, 2026

Viatris (VTRS): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

May 21, 2026

May 20, 2026

Viatris (VTRS) price target increased by 10.47% to 17.48 - MSN

May 20, 2026

May 20, 2026

Viatris Inc. stock rises Wednesday, outperforms market - MarketWatch

May 20, 2026